logo

[breadcrumb_custom]

Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Stock Market Dynamics

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Xeris Biopharma Holdings Inc’s current trading price is -30.83% away from its 52-week high, while its distance from the 52-week low is 80.40%. The stock’s price range for this time frame has been between $1.25 and $3.26. The trading volume of the company’s shares in the Healthcare reached around 1.25 million for the day, which was evidently lower than the average daily volume of 2.39 million over the last three months.

The stock market performance of Xeris Biopharma Holdings Inc has been very steady. Over the last year, the company’s stock hit its highest at $3.26 on 02/15/24, while the lowest price during the same time frame was $1.25, recorded on 03/24/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Xeris Biopharma Holdings Inc (XERS) has experienced a quarterly rise of 6.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 316.71M and boasts a workforce of 377 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.29, with a change in price of +0.54. Similarly, Xeris Biopharma Holdings Inc recorded 2,004,414 in trading volume during the last 100 days, posting a change of +31.03%.

XERS Stock Stochastic Average

Xeris Biopharma Holdings Inc’s raw stochastic average for the past 50 days is currently at 16.23%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 16.30%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 7.76% and 5.10%, respectively.

XERS Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -4.04%. However, over the last six months, the performance has been weaker by 8.41%. The price of XERS decreased -29.75% over the last 30 days. And in the last five days, it has fallen by -4.04%.

On Key

Related Posts